Page 5 - 《中国药房》2022年4期

CHINA PHARMACY

Volume 33，Number 4，February 28，2022

Semimonthly
Table of Contents

Empirical study on the influential factors of the drug complaint and reporting system in China ……………………
…………………………………………………………………… LIANG Yun，WANG Guangping，SHAO Rong（385）

Investigation and analysis on the parents’behavior of children’s use of antibiotics in Sichuan-Chongqing area …
……………………………………………………………………………… CHEN Siqi，ZHENG Hang，YAN Bo（391）
Empirical analysis on the regional characteristics and trend of pharmaceutical industry transfer in China …………
………………………………………………………………………… WANG Hanxi，WANG Qun，CHU Shuzhen（395）
Risk analysis and suggestions of 570 drug wholesale enterprises in Hunan province ………………………………
…………………………………………………… HAI Le，HUANG Dan，WANG Dan，YU Yong，LIN Xinwen（403）
Improvement of the quality standard of Gerbera piloselloides ………………………………………………………

………… YANG Guixiang，WU Yingying，MA Xue，LIU Chunhua，ZHENG Lin，LI Yongjun，WANG Yonglin（408）
Preparation and quality evaluation of Leonurine hydrochloride tablets ………………………………………………
………………………………………… HE Guoyi，ZHOU Dongyang，ZHOU Kai，CHEN Guoguang，REN Lili（413）
Study on nephrotoxicity of the extracts from different parts of Miao medicine Wikstroemia indica ………………
REN Chenchen，FENG Guo，LI Wei，WANG Jianke，PENG Lizhen，ZHU Guanglin，WANG Wenjing，SU Hongmei（419）
Fingerprint establishment of Scutellaria barbata standard decoction and chemical pattern recognition of anti-
oxidant components ……………………………………………… DU Yilong，LI Sai，LI Yanrong，PAN Haifeng（425）
Pharmacokinetic difference of Shenxiong glucose injection in normal and acute myocardial ischemia rats ………

…………………………………… ZHANG Jingya，LIU Liqin，LI Rong，LU Yuan，PAN Jie，LIU Ting，SUN Jia（433）
Establishment of fingerprint，chemometric analysis and multi-component content determination of Zhuang medi-
cine Jinmu granules …………………………………………………………………………………………………
……………… LI Linjie，XIE Tanfang，WANG Yuhan，WANG Zhiping，LI Fang，WANG Xiaoxun，FENG Qiao（439）
GC-MS analysis and anti-inflammatory activity of low polarity parts from 3 species of Sabia genus ……………
……………………………………………………… CUI Renjie，HU Dan，DENG Lulu，LI Jiang，MU Shuzhen（446）
Establishment of the fingerprint of Temurin-5 powder and content determination of 4 components ………………

…………………………………………………… SUN Cancan，ZHOU Jing，Subiyinuer·Tuerhong，MA Guizhi（452）
Optimization of formulation and preparation technology of Neuritic acid oral emulsion …………………………
………………………… CHEN Wenjing，FU Jialei，SUN Dandan，YU Beibei，SHENG Lisong，YAN Xuesheng（458）
Metabolism of four diterpenoids of Euphorbia fischeriana in liver microsomes of rats ……………………………
…………………………… MA Tiancheng，MA Yukun，SUN Jia，ZHANG Jinling，GUO Lina，LIU Qi，SUN Yu（465）
In vitro inhibitory effects of realgar nanoparticles on MCF-7 breast cancer stem cells ………………………………
…………………………… WU Jun，WANG Gui，CHEN Yi，WANG Weiting，JIANG Shuang，WANG Xiaobo（473）
Cost-utility analysis of pertuzumab combined with trastuzumab and docetaxel in first-line treatment of HER2-
positive metastatic breast cancer …………… JIA Caifeng，ZHANG Sen，XU Hao，LI Sainan，WANG Mingxia（481）

Discussion on calculation methods of drug market share in budget impact analysis …………………………………
…………………………………………………………………………… ZHANG Meng，CHEN Lei，XI Xiaoyu（487）
Clinical observation of rimazolom for painless gastroscopy sedation in outpatients …………………………………
…… ZHANG Yi，YE Gang，ZHANG Liang，LI Sitong，XIANG Jun，MOU Junying，YAO Nana，ZHU Xianlin（492）